18/03/2026
Following the recent meningococcal B (MenB) cases reported in Kent, we understand that patients and families may be concerned about the risk of infection.
Meningococcal disease is a rare but serious bacterial infection that can cause meningitis and septicaemia. Vaccination remains the most effective way to protect against MenB.
In the UK, the MenB vaccine (Bexsero) is routinely offered as part of the NHS childhood immunisation programme (for those born after 1st May 2015) to infants at 8 weeks, 16 weeks, and 1 year of age. This programme provides strong protection for those at highest risk.
At present, there is no change to national vaccination guidance. The MenB vaccine is not routinely offered to older children or adults on the NHS unless they are in specific high-risk groups.
Please note that we are currently unable to provide private MenB vaccinations at this practice due to wider supply constraints. Patients who wish to access the vaccine privately may wish to contact alternative providers, such as travel clinics or private healthcare services.
We encourage patients to:
Ensure their children are up to date with all routine vaccinations
Be aware of the symptoms of meningococcal disease (such as fever, headache, vomiting, rash, neck stiffness, or sensitivity to light)
Seek urgent medical attention if symptoms develop
If you have concerns about your child’s vaccination status or believe you may be at increased risk, please contact the practice for advice.
We will continue to follow guidance from the UK Health Security Agency and NHS England and will update patients if recommendations change.
